Medlab Clinical Share Price and Company Fundamentals
Last traded: Today at 5:53 AM
Medlab Clinical Limited, a medical research and development facility, engages in the nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. Medlab Clinical Limited was founded in 2012 and is headquartered in Botany, Australia.
|Primary activities||Nutritional pharmaceutical research and development.|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||66 McCauley Street Alexandria NSW 2015 Australia|
|Phone / Fax||61 2 8188 0311 / 61 2 9699 3347|
|Share registry||ADVANCED SHARE REGISTRY SERVICES|
Medlab Clinical does not pay dividends.
As of May 2021, following are the company executives and directors listed on Medlab Clinical.
|Dr. Sean Michael Hall||CEO & Director||379.11k|
|Mr. Ian Curtinsmith||Chief Information Officer||71.2k|
|Mr. Drew Anthony Townsend||Company Sec. & Non-Exec. Director||55||60.23k|
|Dr. Luis Vitetta BSc(Hons), Grad Dip, Ph.D., Grad Dip Nutr||Director of Medical Research||304.07k|
|Dr. David A. Rutolo||Director of Science||192.44k|
|Mr. Simon Allsop||Chief Financial Officer|
|Mr. Tony Potter||Director of Pharmaceuticals Sales, Marketing & Education|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Medlab Clinical is 58.17M and its enterprise value is 42.61M. The enterprise value to revenue ratio of MDC is 14.47.
The MDC's stocks Beta value is 1.15 making it 15% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Medlab Clinical (MDC)
Medlab Clinical (ASX:MDC) Frequently Asked Questions
1. What is Medlab Clinical's Stock Symbol?
Medlab Clinical trades on ASX under the ticker symbol "MDC".
2. What is Medlab Clinical's stock price today?
One share of MDC stock can currently be purchased for approximately $0.17.
3. How can I contact Medlab Clinical?
Medlab Clinical's mailing address is 66 McCauley Street Alexandria NSW 2015 Australia. The company can be reached via phone at 61 2 8188 0311.
4. What is Medlab Clinical's official website?
The official website of Medlab Clinical is http://www.medlab.co.
5. Which share registry manages Medlab Clinical's stock?
Medlab Clinical's stock is managed by ADVANCED SHARE REGISTRY SERVICES.